TABLE 3.
N in R1 and R2 measured in phase 2 by improved or reevaluated limiting-dilution assays
| Sample and laboratory | Sample | N/ml (109) |
|---|---|---|
| R1a | ||
| 2 | A | 5.8 |
| 1b | R1 | 4.9 |
| 8 | A | 3.2 |
| 1a | R1 | 2.1 |
| 2 | B | 2.0 |
| 2 | R1 | 1.7 |
| 8 | R1 | 0.96 |
| 8 | B | 0.93 |
| R2b | ||
| 8 | R2 | 3.9 |
| 2 | D | 3.5 |
| 2 | C | 3.4 |
| 2 | R2 | 3.1 |
| 1a | R2 | 2.5 |
| 8 | C | 2.1 |
| 8 | D | 1.2 |
| 1b | R2 | 0.96 |
GMV, 2.2 × 109/ml; 95% CI, 1.3 × 109 to 3.7 × 109/ml.
GMV, 2.3 × 109/ml; 95% CI, 1.6 × 109 to 3.5 × 109/ml.